Forest Labs Sues Six More Companies Over Namenda

Law360, New York (January 25, 2008, 12:00 AM EST) -- Forest Laboratories Inc. has filed another infringement suit against six generic drug makers, including Ranbaxy Inc. and Mylan Pharmaceuticals Inc., over a patent for its Alzheimer’s drug Namenda, just over two weeks after bringing patent infringement claims against seven other companies.

The complaint filed Friday in the U.S. District Court for the District of Delaware by Forest and Merz Pharma GmbH & Co. KgaA is similar to the two suits filed by the companies in the same court on Dec. 10 against generic makers including Teva...
To view the full article, register now.